SUNDAY WILSON: Open Payments
NPI 1497765432 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 10 payments from 9 companies in 2025. Trend: 2023 $123 · 2024 $43 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $123 |
| UCB, Inc. | 1 | $47 |
| BioCryst US Sales Co., LLC | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| CSL Behring | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: KRYSTEXXA, Bimzelx, ORLADEYO, ACTHAR, AIRSUPRA, Andembry, TAKHZYRO, Xolair.
Industry payments across TX — which companies pay providers there.
